Adoption of Novel Drug Financing Strategies Across Managed Care Organizations
Ulrich Neumann, Sr. Director & Head US Access & Commercial Strategy | Isha Bangia, Manager, US Market Access | Maximilian Vargas, Sr. Director, US Access Strategy & Acct Mgmt |
This research assesses both, status quo of novel payment strategies across Commercial and Medicare lives, and opportunities for future expansion within three years. Despite heightened excitement around innovative financing models, MCOs in the US see limited to no current use, and they have narrow plans of future implementation. But we found that some pockets of the future do exist in the present.